Technology Development Center, Covalent Materials Co., Ltd., Kanagawa, Japan.
Tissue Eng Part C Methods. 2013 Jun;19(6):438-48. doi: 10.1089/ten.TEC.2012.0166. Epub 2012 Dec 16.
Human mesenchymal stem cells (hMSCs) that can differentiate into chondrocytes are a potential autologous cell source for repair of damaged tissue. Current methods usually induce the formation of all three chondrocyte phenotypes, hyaline, fibrous, and elastic, without the ability to selectively induce only one of them. By controlling the size of hMSC cell clusters, it may be possible to direct differentiation more uniformly toward hyaline chondrocytes. We designed new cell culture platforms containing microwells of different diameters. The platforms and wells were composed of a zirconia ceramics substratum. hMSCs briefly adhered to the substratum before releasing and entering the microwells. The physical restraints imposed by the microwells enabled hMSC clusters to homogenously differentiate into hyaline chondrocyte-like cells. Chondrogenic aggregates in microwells expressed the hyaline chondrocyte-specific genes Col II, aggrecan (ACAN), and cartilage oligomeric protein (COMP). The cultures also produced hyaline chondrocyte-specific matrix proteins Col II and ACAN homogenously throughout the aggregates. In contrast, chondrogenesis in pellet cultures was heterogeneous with the expression of nonhyaline chondrocyte genes CD105, Col X, and Col I. In these pellet cultures, hyaline and nonhyaline chondrocyte-specific matrix proteins were distributed heterogeneously. Thus, this novel ceramic microwell substratum technology efficiently directed the differentiation of hyaline chondrocyte-like cells from hMSCs. These results indicate that there is a close relationship between hMSC cluster size regulation in the microwells and differentiation tendency. This microwell culture differentiation method will provide a valuable experimental system for both experimental and potential clinical studies.
人骨髓间充质干细胞(hMSCs)可分化为软骨细胞,是修复受损组织的潜在自体细胞来源。目前的方法通常诱导形成透明软骨细胞、纤维软骨细胞和弹性软骨细胞这三种软骨细胞表型,但不具备选择性地诱导其中一种的能力。通过控制 hMSC 细胞簇的大小,有可能更均匀地将分化方向引导为透明软骨细胞。我们设计了包含不同直径微井的新型细胞培养平台。这些平台和微井由氧化锆陶瓷衬底组成。hMSC 短暂附着在衬底上,然后释放并进入微井中。微井施加的物理限制使 hMSC 簇均匀地分化为透明软骨细胞样细胞。微井中的软骨生成聚集体表达透明软骨细胞特异性基因 Col II、聚集蛋白聚糖(ACAN)和软骨寡聚蛋白(COMP)。这些培养物还均匀地在聚集体中产生透明软骨细胞特异性基质蛋白 Col II 和 ACAN。相比之下,在微球培养物中的软骨发生具有异质性,表现为非透明软骨细胞基因 CD105、Col X 和 Col I 的表达。在这些微球培养物中,透明软骨细胞和非透明软骨细胞特异性基质蛋白呈不均匀分布。因此,这种新型陶瓷微井衬底技术有效地将 hMSCs 分化为透明软骨细胞样细胞。这些结果表明,微井中 hMSC 细胞簇大小的调节与分化趋势密切相关。这种微井培养分化方法将为实验和潜在的临床研究提供一个有价值的实验系统。